OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
054050$7820.0058

NH NongwooBio Co Ltd

Fishing & FarmingVerified

NH NongwooBio maintains a strong liquidity position, with cash and equivalents amounting to KRW 48,086,313,270, representing 13.63% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 12.37%, indicating a solid ability to meet short-term obligations. The current ratio of 3.34 further supports this, showing that current assets significantly exceed current liabilities. Profitability metrics show that NH NongwooBio's return on equity (ROE) is 4.43%, and return on assets (ROA) is 3.48%. These figures are below the industry median for ROE and ROA in the Food & Beverages sector, suggesting that the company is underperforming in terms of capital efficiency and asset utilization. The company's revenue is distributed across two segments: Seed and Agricultural Material. The Seed segment focuses on vegetable seeds, while the Agricultural Material segment deals with topsoil, fertilizers, and biochar. There is no indication of geographic concentration in the provided data, but the company is based in Korea and operates primarily within the region. Looking at the growth trajectory, the company's revenue is projected to decrease from KRW 158,789,058,610 to KRW 119,800,000,000, a decline of 24.5%. This is supported by analyst estimates and aligns with the company's current financial performance. The operating income is also expected to decline from KRW 13,363,451,850 to KRW 7,500,000,000, a reduction of 43.8%. Risk factors for NH NongwooBio are currently low, with no immediate filing-based liquidity or dilution flags detected. The debt-to-equity ratio is 0.09, indicating a conservative capital structure with minimal leverage. The company's dilution potential is also low, with no significant changes in shares outstanding between basic and diluted shares. Recent events and filings do not show any material changes or significant risks for the company. The company's financial statements and analyst estimates suggest a stable but declining revenue outlook. There are no notable recent events or transcripts that would indicate a shift in the company's strategic direction or operational performance.

30-day price · 054050-590.00 (-7.5%)
Low$7260.00High$8230.00Close$7310.00As of22 May, 00:00 UTC
Profile
CompanyNH NongwooBio Co Ltd
Ticker054050.KQ
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFishing & Farming
AI analysis

Business. NH NongwooBio Co Ltd develops, produces, and sells seeds and agricultural materials, operating through two segments: Seed and Agricultural Material.

Classification. NH NongwooBio is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Fishing & Farming industry with a confidence level of 0.92.

NH NongwooBio maintains a strong liquidity position, with cash and equivalents amounting to KRW 48,086,313,270, representing 13.63% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 12.37%, indicating a solid ability to meet short-term obligations. The current ratio of 3.34 further supports this, showing that current assets significantly exceed current liabilities. Profitability metrics show that NH NongwooBio's return on equity (ROE) is 4.43%, and return on assets (ROA) is 3.48%. These figures are below the industry median for ROE and ROA in the Food & Beverages sector, suggesting that the company is underperforming in terms of capital efficiency and asset utilization. The company's revenue is distributed across two segments: Seed and Agricultural Material. The Seed segment focuses on vegetable seeds, while the Agricultural Material segment deals with topsoil, fertilizers, and biochar. There is no indication of geographic concentration in the provided data, but the company is based in Korea and operates primarily within the region. Looking at the growth trajectory, the company's revenue is projected to decrease from KRW 158,789,058,610 to KRW 119,800,000,000, a decline of 24.5%. This is supported by analyst estimates and aligns with the company's current financial performance. The operating income is also expected to decline from KRW 13,363,451,850 to KRW 7,500,000,000, a reduction of 43.8%. Risk factors for NH NongwooBio are currently low, with no immediate filing-based liquidity or dilution flags detected. The debt-to-equity ratio is 0.09, indicating a conservative capital structure with minimal leverage. The company's dilution potential is also low, with no significant changes in shares outstanding between basic and diluted shares. Recent events and filings do not show any material changes or significant risks for the company. The company's financial statements and analyst estimates suggest a stable but declining revenue outlook. There are no notable recent events or transcripts that would indicate a shift in the company's strategic direction or operational performance.
Key takeaways
  • NH NongwooBio has a strong liquidity position with a current ratio of 3.34 and significant cash reserves.
  • The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is expected to decline by 24.5% in the next fiscal year, with a corresponding drop in operating income.
  • The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.09.
  • There are no immediate liquidity or dilution risks, and the company's risk profile remains low.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$158.79B
Gross profit$77.81B
Operating income$13.36B
Net income$12.29B
R&D
SG&A
D&A
SBC
Operating cash flow$14.93B
CapEx-$5.24B
Free cash flow$9.31B
Total assets$352.92B
Total liabilities$75.22B
Total equity$277.71B
Cash & equivalents$48.09B
Long-term debt$26.05B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$7820.00
Market cap$125.36B
Enterprise value$103.32B
P/E10.2
Reported non-GAAP P/E
EV/Revenue0.7
EV/Op income7.7
EV/OCF6.9
P/B0.5
P/Tangible book0.5
Tangible book$277.71B
Net cash$22.04B
Current ratio3.3
Debt/Equity0.1
ROA3.5%
ROE4.4%
Cash conversion1.2%
CapEx/Revenue-3.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food · cohort 445 companies
Metric054050Activity
Op margin8.4%3.2% medp25 3.2% · p75 3.2%top quartile
Net margin7.7%2.1% medp25 2.1% · p75 2.1%top quartile
Gross margin49.0%9.2% medp25 9.2% · p75 9.2%top quartile
CapEx / revenue-3.3%-3.9% medp25 -9.9% · p75 -1.1%above median
Debt / equity9.0%8.7% medp25 8.7% · p75 8.7%top quartile
Observations
IR observations
Mean EPS estimate653.00 KRW
Mean revenue estimate119,800,000,000 KRW
Mean EBIT estimate7,500,000,000 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:52 UTC#9be97d37
Market quoteclose KRW 7820.00 · shares 0.02B diluted
no public URL
2026-05-10 08:52 UTC#b6a214f7
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:55 UTCJob: 1c82b118